Search results
Results from the WOW.Com Content Network
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
The mechanisms behind allergic asthma—i.e., asthma resulting from an immune response to inhaled allergens—are the best understood of the causal factors. In both people with asthma and people who are free of the disease, inhaled allergens that find their way to the inner airways are ingested by a type of cell known as antigen-presenting ...
Asthmador was a nonprescription treatment for the relief of bronchial asthma made by the R. Schiffmann Company.. It consisted of a mixture of belladonna, stramonium and potassium perchlorate, [1] and was a fine powder intended to be burned and the smoke inhaled.
Clenbuterol is approved for use in some countries as a bronchodilator for asthma. [medical citation needed]Clenbuterol is a β 2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug.
Nasal irrigation can be an effective therapy to relieve symptoms of acute sinusitis caused by upper respiratory tract infections such as the common cold. [1] The evidence for effectiveness in relieving chronic sinusitis is weak. [2] It can also be useful for the temporary relief of the symptoms associated with allergic rhinitis. [3]
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
CEBM is the academic lead for Oxford University's Graduate School in Evidence-Based Healthcare, together with the university's Department of Continuing Education.The Graduate School includes a MSc in Evidence-Based Health Care [2] and a DPhil in Evidence-Based Health Care, [3] along with a range of short courses, including a course on the History and Philosophy of Evidence-Based Healthcare ...